Best Practice & Research Clinical Haematology
Volume 21, Issue 3 , Pages 543-557 , September 2008

Targeting haematopoietic-specific minor histocompatibility antigens to distinguish graft-versus-tumour effects from graft-versus-host disease

  • Robbert Spaapen, MSc (Research Associate in Haematology)
    • ,
  • Tuna Mutis, MD, PhD (Assistant Professor in Haematology)

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +31 (0) 88 755 6504; Fax: +31 (0) 88 755 5418.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1521-6926(08)00052-2

doi: 10.1016/j.beha.2008.06.001

Best Practice & Research Clinical Haematology
Volume 21, Issue 3 , Pages 543-557 , September 2008

Article Tools

* Image Usage & Resolution